Duaklir Pressair and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Duaklir Pressair and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aclidinium / formoterol
Brand name: Duaklir Pressair
Synonyms: n.a.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Duaklir Pressair-Insulin glargine, recombinant Subcutaneous
- Duaklir Pressair-Insulin glulisine
- Duaklir Pressair-Insulin Glulisine (Cartridges and Pens)
- Duaklir Pressair-Insulin Glulisine (Vials)
- Duaklir Pressair-Insulin glulisine Subcutaneous
- Duaklir Pressair-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Dual Action Complete
- Insulin glargine and lixisenatide Subcutaneous-Duavee
- Insulin glargine and lixisenatide Subcutaneous-Duavee (combination)
- Insulin glargine and lixisenatide Subcutaneous-Duet DHA
- Insulin glargine and lixisenatide Subcutaneous-Duet DHA 400
- Insulin glargine and lixisenatide Subcutaneous-Duet DHA Balanced